With improved standards of living, the incidence of multiple metabolic disorders has
increased year by year, especially major risk factors for cardiovascular disease such as …

Brown adipose tissue (BAT) is considered an interesting target organ for the treatment of
metabolic disease due to its high metabolic capacity. Non-shivering thermogenesis, once …

Obesity plays a major role in type II diabetes (T2DM) progression because it applies
metabolic and oxidative stress resulting in dysfunctional beta-cells and activation of intra …

Background Childhood obesity remains a public health concern, and tracking local progress
may require local surveillance systems. Electronic health record data may provide a cost …

IN BRIEF Patients with obesity and type 2 diabetes are key targets for weight loss. Given the
lack of behavioral weight loss in most patients, obesity pharmacotherapy options should be …

BACKGROUND: Managed care organizations put great effort into managing the population
of patients with type 2 diabetes mellitus (T2DM) because of the health and economic burden …

Aims Examine the association between weight loss and adherence with glycaemic goal
attainment in patients with inadequately controlled T2 DM. Materials and methods Patients≥ …

Introduction Alogliptin is an oral antihyperglycemic agent that is a selective inhibitor of the
enzyme dipeptidyl peptidase-4 (DPP-4), approved for the treatment of type 2 diabetes …

Aims The study aims to examine real‐world weight change and the role of medication
adherence among patients with type 2 diabetes who initiated one of three drug classes …

Objective To improve the health of people with diabetes, it is essential to identify why
patients experience extended periods of poor glycemic control before therapeutic …